Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study

Authors:	Bonello Laurent Camoin-Jau Laurence Arques Stéphane Boyer Christian Panagides Dimitri Wittenberg Olivier Simeoni Marie-Claude Barragan Paul Dignat-George Françoise Paganelli Franck

Affiliation:	^? Service de Cardiologie, Hôpital Universitaire Nord, Marseille, France;^† Laboratoire d’Hématologie, Unité INSERM UMRS 608, Hôpital de la Conception, Marseille, France;^‡ Service de Cardiologie, Hôpital d’Aubagne, Aubagne, France;^§ Service de Cardiologie, Clinique Clairval, Marseille, France;^∥ Service de Cardiologie, Clinique Bouchard, Marseille, France;^¶ Service de Cardiologie, Hôpital Privé Beauregard, Marseille, France;^# Laboratoire de Statistique, Faculté de la Timone, Marseille, France;^?? Service de Cardiologie, Polyclinique les Fleurs, Ollioules, France.

Abstract:

Keywords:	ADP, adenosine diphosphate MACE, major adverse cardiac events MFI, mean fluorescence intensity NSTEMI, non–ST-segment elevation myocardial infarction PCI, percutaneous coronary intervention PGE1, prostaglandin E1 TIMI, Thrombolysis In Myocardial Infarction VASP, vasodilator-stimulated phosphoprotein
本文献已被 ScienceDirect PubMed 等数据库收录！